Bio-Path Holdings, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $3.49M.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was -$16.00K, a 103.18% decline year-over-year.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $5.64M.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was -$79.00K.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for fiscal 2024 was $9.04M, a 1741.34% increase from fiscal 2023.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for fiscal 2023 was $491.00K, a 71.68% decline from fiscal 2022.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for fiscal 2022 was $1.73M, a 89.06% decline from fiscal 2021.
- Bio-Path Holdings, Inc. stock issued during period, value, new issues for fiscal 2021 was $15.85M, a 269.53% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $9.04M 10-K · filed 2025-03-27 |
| 2024-09-30 | -$16.00K 10-Q · filed 2024-11-14 | $5.54M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $5.64M 10-Q · filed 2025-08-14 | $6.06M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$79.00K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $491.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $503.00K 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $1.73M 10-K · filed 2024-03-07 | |
| 2021-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $15.85M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.40M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | |
| 2021-03-31 | $14.45M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $4.29M 10-K · filed 2022-03-10 | |
| 2019-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $26.70M 10-K · filed 2021-03-09 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $19.41M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $20.59M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $19.41M 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $1.18M 10-K · filed 2020-03-05 |
| 2018-09-30 | $1.18M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $3.57M 10-K · filed 2019-03-19 | |
| 2016-12-31 | $4.39M 10-K · filed 2018-04-02 | |
| 2014-12-31 | $13.81M 10-K · filed 2017-03-15 |